DO + CO AG/ AT0000818802 /
27/06/2024 12:30:35 | Chg. +4.60 | Volume | Bid13:14:32 | Ask13:14:32 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
164.40EUR | +2.88% | 0 Turnover: 0.00 |
164.40Bid Size: 30 | 165.20Ask Size: 30 | 1.61 bill.EUR | 0.61% | 47.91 |
GlobeNewswire
13:30
MW Storage and Fluence deepen partnership to deliver their third energy storage project in Finland
GlobeNewswire
13:30
Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Base...
GlobeNewswire
13:18
TDC COURT DEADLINE NOTICE: Teradata Corp. (NYSE:TDC) has been Sued for Securities Fraud, Investors a...
GlobeNewswire
13:14
SPT COURT DEADLINE NOTICE: Sprout Social, Inc. (Nasdaq:SPT) has been Sued for Securities Fraud, Inve...
GlobeNewswire
13:09
PWSC ACQUISITION NEWS: PowerSchool’s (NYSE:PWSC) $22.80 Per Share Deal is Being Reviewed by BFA Law,...
GlobeNewswire
13:05
Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Supracho...
GlobeNewswire
13:04
PATH COURT DEADLINE NOTICE: UiPath, Inc. (NYSE:PATH) has been Sued for Securities Fraud, Investors a...
GlobeNewswire
13:02
CAE SHAREHOLDER NOTIFICATION: CAE, Inc.’s (NYSE:CAE) Impairment Charges are Being Reviewed by BFA La...
GlobeNewswire
13:01
CRM SHAREHOLDER NOTIFICATION: Salesforce, Inc. (NYSE:CRM) is Being Investigated for Securities Fraud...
GlobeNewswire
13:00
Canoo Honored with Multiple Red Dot 2024 Design Awards for Exceptional Design Innovation of Commerci...
GlobeNewswire
13:00
Jet.AI Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants
GlobeNewswire
12:40
Cellectar Biosciences to Host Key Opinion Leader Event to Review the Full Results from Its CLOVER Wa...
GlobeNewswire
12:00
Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Inte...
GlobeNewswire
12:00
FUTUREFUEL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed A...
GlobeNewswire
12:00
GenVivo Announces Initiation of Patient Dosing in a US Phase I/Ib Clinical Trial Evaluating GEN2, a ...
GlobeNewswire
11:56
Cost of new drug development is key concern for life science as focus shifts to repurposing
GlobeNewswire
10:00
OKX's 20th Monthly Proof of Reserves Showcases USD22.4 Billion in Primary Assets Backing Customer Fu...